This list is an analysis based on recent market events. It's not an investment recommendation.
About
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
Show more...
CEO
Ms. Caroline J. Loew Ph.D.
Employees
116
Country
IE
ISIN
IE000LK2BOB4
Listings
0 Comments
Share your thoughts
FAQ
What is Mural Oncology stock price today?▼
The current price of MURA is $2.04 USD — it has increased by +0% in the past 24 hours. Watch Mural Oncology stock price performance more closely on the chart.
What is Mural Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mural Oncology stocks are traded under the ticker MURA.
Is Mural Oncology stock price growing?▼
MURA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Mural Oncology has showed a +54.55% increase.
What is Mural Oncology revenue for the last year?▼
Mural Oncology revenue for the last year amounts to 0 USD.
What is Mural Oncology net income for the last year?▼
MURA net income for the last year is -257.03M USD.
How many employees does Mural Oncology have?▼
As of April 02, 2026, the company has 116 employees.
In which sector is Mural Oncology located?▼
Mural Oncology operates in the Health Care sector.
When did Mural Oncology complete a stock split?▼
Mural Oncology has not had any recent stock splits.